A clinicopathological correlation of 67 eyes primarily enucleated for advanced intraocular retinoblastoma

British Journal of Ophthalmology

Volumn 95, Issue 4, 2011, Pages 553-558

  Wilson, Matthew W ^a,b   Qaddoumi, Ibrahim ^a,b   Billups, Catherine ^b   Haik, Barrett G ^a,b   Rodriguez Galindo, Carlos ^a,b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADOLESCENT; ADVANCED CANCER; ARTICLE; BILATERAL CANCER; BONE MARROW BIOPSY; CANCER ADJUVANT THERAPY; CANCER CLASSIFICATION; CANCER GROWTH; CANCER INVASION; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; CORNEAL DIAMETER; DISEASE SEVERITY; ENUCLEATION; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; INFANT; INTERNATIONAL CLASSIFICATION OF DISEASES; INTRAOCULAR HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RETINOBLASTOMA; RETROSPECTIVE STUDY; TUMOR DIFFERENTIATION; TUMOR VASCULARIZATION; VISUAL SYSTEM PARAMETERS;

CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; EYE ENUCLEATION; FEMALE; HUMANS; INFANT; INTRAOCULAR PRESSURE; MALE; RETINAL NEOPLASMS; RETINOBLASTOMA; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 79952925487     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2009.177444     Document Type: Article

References (32)

1. Ellsworth RM. The practical management of retinoblastoma. Trans Am Ophthalmol Soc 1969;67:462-534.
2. de Sutter E, Havers W, Hopping W, et al. The prognosis of retinoblastoma in terms of survival. A computer assisted study. Part II. Ophthalmic Paediatr Genet 1987;8:85-8.
3. Singh AD, Shields CL, Shields JA. Prognostic factors in retinoblastoma. J Pediatr Ophthalmol Strabismus 2000;37:1-8.
4. Kopelman JE, McLean IW, Rosenberg SH. Multivariate analysis of risk factors for metastasis in retinoblastoma treated by enucleation. Ophthalmology 1987;94:371-7. (Pubitemid 17056025)
5. Messmer EP, Heinrich T, Höpping W, et al. Risk factors for metastasis in patients with retinoblastoma. Ophthalmology 1991;98:136-41.
6. Hungerford J. Factors influencing metastasis in retinoblastoma. Br J Ophthalmol 1993;77:541. (Pubitemid 23281448)
7. Khelfaoui F, Validire P, Auperin A, et al. Histopathologic risk factors in retinoblastoma: a retrospective study of 172 patients treated in a single institution. Cancer 1996;77:1206-13. (Pubitemid 26080915)
8. Chong EM, Coffee RE, Chintagumpala M, et al. Extensively necrotic retinoblastoma is associated with high-risk prognostic factors. Arch Pathol Lab Med 2006;130:1669-72. (Pubitemid 44683795)
9. Chantada GL, Casco F, Fandiño AC, et al. Outcome of patients with retinoblastoma and postlaminar optic nerve invasion. Ophthalmology 2007;114:2083-9. (Pubitemid 350016354)
10. Shields CL, Shields JA, Baez K, et al. Optic nerve invasion of retinoblastoma. Metastatic potential and clinical risk factors. Cancer 1994;73:692-8.
11. Shields CL, Shields JA, Baez K, et al. Choroidal invasion of retinoblastoma: metastatic potential and clinical risk factors. Br J Ophthalmol 1993;77:544-8. (Pubitemid 23281450)
12. Atchaneeyasakul LO, Wongsiwaroj C, Uiprasertkul M, et al. Prognostic factors and treatment outcomes of retinoblastoma in pediatric patients: a single-institution study. Jpn J Ophthalmol 2009;53:35-9.
13. Children's Oncology Group. Phase III study of adjuvant vincristine, carboplatin, and etoposide or observation only in patients with newly diagnosed unilateral retinoblastoma with or without histopathological high-risk features after enucleation. National Cancer Institute. First published: June 2, 2006. Last Modified: February 25, 2010. http://www.cancer.gov/search/ ViewClinicalTrials.aspx?cdrid=483043&version=HealthProfessional& protocolsearchid=7401641 (accessed 27 Feb 2010).
14. Bellaton E, Bertozzi AI, Behar C, et al. Neoadjuvant chemotherapy for extensive unilateral retinoblastoma. Br J Ophthalmol 2003;87:327-9. (Pubitemid 36307909)
15. Armenian SH, Panigrahy A, Murphree AL, et al. Management of retinoblastoma with proximal optic nerve enhancement on MRI at diagnosis. Pediatr Blood Cancer 2008;51:479-84.
16. Demirci H, Eagle RC, Shields CL, et al. Histopathological findings in eyes with retinoblastoma treated only with chemoreduction. Arch Ophthalmol 2003;121:1125-31. (Pubitemid 36962166)
17. Balaguer J, Wilson MW, Bilups CA, et al. Predictive factors of invasion in eyes with retinoblastoma enucleated after eye salvage treatments. Pediatr Blood Cancer 2009;52:351-6.
18. Murphree AL. Intraocular retinoblastoma: the case for a new group classification. Ophthalmol Clin North Am 2005;18:41-53. (Pubitemid 40348809)
19. Sastre X, Chantada GL, Doz F, et al. Proceedings of the Consensus Meetings From the International Retinoblastoma Staging Working Group on the Pathology Guidelines for the Examination of Enucleated Eyes and Evaluation of Prognostic Risk Factors in Retinoblastoma. Arch Pathol Lab Med 2009;133:1199-202.
20. Shields CL, Mashayekhi A, Au AK, et al. The International Classification of Retinoblastoma predicts chemoreduction success. Ophthalmology 2006;113:2276-80. (Pubitemid 44838917)
21. Honavar SG, Singh AD, Shields CL, et al. Postenucleation adjuvant therapy in high-risk retinoblastoma. Arch Ophthalmol 2002;120:923-31. (Pubitemid 34755545)
22. Schueler AO, Hosten N, Bechrakis NE, et al. High resolution magnetic resonance imaging of retinoblastoma. Br J Ophthalmol 2003;87:330-5. (Pubitemid 36307910)
23. Wilson MW, Rodriguez-Galindo C, Billups C, et al. Lack of correlation between the histology and magnetic resonance imaging of the optic nerve involvement in retinoblastoma. Ophthalmology 2009;116:1558-63.
24. de Graaf P, Barkhof F, Moll AC, et al. Retinoblastoma: MR imaging parameters in detection of tumor extent. Radiology 2005;235:197-207. (Pubitemid 40432255)
25. Brisse HJ, Guesmi M, Aerts I, et al. Relevance of CT and MRI in retinoblastoma for the diagnosis of postlaminar invasion with normal-size optic nerve: a retrospective study of 150 patients with histological comparison. Pediatr Radiol 2007;37:649-56. (Pubitemid 46929939)
26. Lemke A, Kazi I, Mergner U, et al. Retinoblastoma - MR appearance using a surface coil in comparison with histopathological results. Eur Radiol 2007;17:49-60. (Pubitemid 46063028)
27. de Graaf P, Moll AC, Imhof SM, et al. Retinoblastoma and optic nerve enhancement on MRI: not always extraocular extension tumour extension. Br J Ophthalmol 2006;90:800-1. (Pubitemid 43835510)
28. Howarth C, Meyer D, Hustu HO, et al. Stage-related combined modality treatment of retinoblastoma: Results a prospective study. Cancer 1980;45:851-8. (Pubitemid 10129832)
29. Pratt CB, Crom DB, Howarth C. The use of chemotherapy for extraocular retinoblastoma. Med Pediatr Oncol 1985;13:330-3. (Pubitemid 16193425)
30. Mustafa MM, Jamshed A, Khafaga Y, et al. Adjuvant chemotherapy with vincristine, doxorubicin, and cyclophosphamide in the treatment of post-enucleation high-risk retinoblastoma. J Pediatr Hematol Oncol 1999;21:364-9. (Pubitemid 30306004)
31. Chantada GL, Guitter MR, Frandiño AC, et al. Treatment results in patients with retinoblastoma and invasion to the cut end of the optic nerve. Pediatr Blood Cancer 2009;52:218-22.
32. Dunkel IJ, Aledo A, Kernan NA, et al. Successful treatment of metastatic retinoblastoma. Cancer 2000;89:2117-21.